Skip to Content

Cabergoline for Hyperprolactinemia

Cabergoline (Dostinex - Pharmacia & Upjohn), an ergot alkaloid derivative recently marketed for treatment of hyperprolactinemia, is a selective D2 dopamine agonist that inhibits prolactin-secreting cells in the pituitary. Bromocriptine (Parlodel - Sandoz), the drug most commonly used for this condition, is also a D2 agonist, but affects D1 receptors as well....
Cannot Access - We are sorry, but you cannot access the requested article.
login now
login now
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Cabergoline for Hyperprolactinemia
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1003
Article Code: 1003b
Date: June 20, 1997
Volume: 39
Pages: 58-59

 Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.
 Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article.